Monopar Therapeutics Inc (MNPR)
Healthcare
Biotechnology
108.40 $
-5.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Monopar Therapeutics Inc (MNPR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 61.6% of the shares are freely tradable; institutional investors hold 93.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
93.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
23.2%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
61.6%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
34.1%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
7Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| HHG PLC | 19.67 | 1,317,410 | +0.0 | 03/31/2026 |
| RA Capital Management, LLC | 9.96 | 667,207 | +0.0 | 03/31/2026 |
| Saturn V Capital Management LLC | 5.16 | 345,626 | +6.1 | 03/31/2026 |
| Deerfield Management Co | 4.83 | 323,745 | +89.8 | 03/31/2026 |
| BlackRock Inc | 4.73 | 316,567 | +24.2 | 03/31/2026 |
| Adage Capital Partners Gp LLC | 4.62 | 309,195 | -51.6 | 03/31/2026 |
| Vanguard Group Inc | 4.39 | 293,816 | +41.1 | 12/31/2025 |
| Siren, L.L.C. | 4.03 | 270,118 | +27.2 | 03/31/2026 |
| ADAR1 Capital Management LLC | 3.95 | 264,278 | +13.0 | 03/31/2026 |
| Polar Capital Holdings PLC | 3.38 | 226,526 | +114.2 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.